|
1.
|
|
|
2.
|
|
|
3.
|
The mutational status of platelet-receptor PEAR1 was recently identified as a major factor for survival of young patients with Acute Myeloid Leukemia. While studies show [...]
2024 |
Abstract |
|
|
4.
|
|
|
5.
|
Identification of druggable mutations in Acute Myeloid Leukemia (AML), such as FLT3-ITD, has led to the development of targeted therapies capable of out-performing cytoto [...]
2022 |
Abstract |
|
|
6.
|
In this work, I explored epigenetic dysregulation AML by Chromatin dynamics in acute myeloid leukemia subsets defined by genetic and drug response diversity and the ident [...]
2022 |
Dissertation |
|
|
7.
|
|
|
8.
|
Acute Myelogenous Leukemia (AML) is an aggressive cancer of the bone marrow that affects both adults and children alike. While many patients achieve remission following i [...]
2020 |
Dissertation |
|
|
9.
|
Acute Myeloid Leukemia (AML) is an aggressive cancer with poor overall survival due to frequent relapse. FMS-like tyrosine kinase (FLT3) is the most commonly mutated gene [...]
2022 |
Abstract |
|
|
10.
|
|
